Cardinal Capital Management Inc (Canada)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5M Sell
206,451
-1,019
-0.5% -$119K 0.64% 45
2026
Q1
$25M Sell
207,470
-97,064
-32% -$11.2M 0.67% 43
2025
Q4
$44M Buy
304,534
+10,659
+4% +$1M 0.99% 29
2025
Q3
$24.7M Buy
293,875
+24,204
+9% +$1.99M 0.71% 42
2025
Q2
$21.3M Buy
269,671
+3,065
+1% +$244K 0.67% 44
2025
Q1
$23.9M Buy
266,606
+35,754
+15% +$3.34M 0.81% 40
2024
Q4
$23M Buy
230,852
+4,588
+2% +$473K 0.78% 41
2024
Q3
$25.7M Buy
226,264
+4,624
+2% +$549K 1.06% 32
2024
Q2
$27.4M Buy
221,640
+1,227
+0.6% +$158K 1.06% 29
2024
Q1
$29.1M Sell
220,413
-71,993
-25% -$8.87M 1.29% 25
2023
Q4
$31.9M Sell
292,406
-8,939
-3% -$928K 1.51% 18
2023
Q3
$31M Buy
301,345
+2,373
+0.8% +$256K 1.62% 18
2023
Q2
$34.5M Sell
298,972
-9,825
-3% -$1.12M 1.73% 17
2023
Q1
$32.9M Sell
308,797
-70,960
-19% -$7.66M 1.78% 15
2022
Q4
$42.1M Buy
379,757
+2,236
+0.6% +$229K 2.38% 14
2022
Q3
$32.5M Sell
377,521
-6,245
-2% -$557K 1.98% 14
2022
Q2
$35M Sell
383,766
-1,378
-0.4% -$122K 1.93% 13
2022
Q1
$31.6M Buy
385,144
+11,289
+3% +$890K 1.54% 13
2021
Q4
$28.7M Buy
373,855
+737
+0.2% +$58.7K 1.34% 19
2021
Q3
$28M Buy
373,118
+2,109
+0.6% +$160K 1.53% 16
2021
Q2
$28.9M Buy
371,009
+12,851
+4% +$956K 1.56% 14
2021
Q1
$26.3M Buy
358,158
+134,056
+60% +$9.89M 1.55% 16
2020
Q4
$17.5M Buy
224,102
+12,060
+6% +$922K 1.06% 31
2020
Q3
$16.8M Buy
212,042
+4,051
+2% +$317K 1.2% 24
2020
Q2
$15.3M Buy
207,991
+16,993
+9% +$1.28M 1.3% 25
2020
Q1
$14M Buy
190,998
+26,939
+16% +$2.12M 1.17% 25
2019
Q4
$14.2M Buy
164,059
+40,254
+33% +$3.31M 0.96% 32
2019
Q3
$9.95M Buy
123,805
+10,563
+9% +$847K 0.93% 32
2019
Q2
$9.06M Buy
113,242
+102,238
+929% +$7.83M 0.9% 31
2019
Q1
$873K Hold
11,004
0.09% 37
2018
Q4
$802K Sell
11,004
-629
-5% -$44.4K 0.09% 35
2018
Q3
$787K Hold
11,633
0.08% 41
2018
Q2
$674K Buy
+11,633
New +$656K 0.07% 42

Other funds holding MRK

Cardinal Capital Management Inc (Canada)'s MRK Position: Q2 2026 in Review

Cardinal Capital Management Inc (Canada) reduced its Merck (MRK) stake by 0.49% in Q2 2026, selling an estimated $119K and leaving 206,451 shares worth $26.5M. The position accounts for 0.64% of the portfolio, ranked #45.

Cardinal Capital Management Inc (Canada) first reported a position in MRK in Q2 2018 and has held it in 33 quarters since. The position peaked at $44M in Q4 2025. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cardinal Capital Management Inc (Canada) held 206,451 shares of Merck worth $26.5M as of Q2 2026.
  • Cardinal Capital Management Inc (Canada) sold 1,019 Merck shares in Q2 2026, an estimated $119K.
  • Merck made up 0.64% of Cardinal Capital Management Inc (Canada)'s portfolio in Q2 2026, its #45 holding.
  • Cardinal Capital Management Inc (Canada) first reported a position in Merck in Q2 2018 and has held it in 33 quarters since.
  • Cardinal Capital Management Inc (Canada)'s Merck position peaked at $44M in Q4 2025.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q2 2026, filed 10 Jul 2026.